Persistent Asset Partners »

Arrowhead Pharmaceuticals shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $167k 2.7k 62.70

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Vanguard Portfolio Management
FMR
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Fred Alger Management
Invesco
Slate Path Capital
Vestal Point Capital
Arrowstreet Capital, Limited Partnership
Baker Bros. Advisors
Driehaus Capital Management

View all funds holding Arrowhead Pharmaceuticals